Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VENXXIVATM safely and effectively. See full prescribing information for VENXXIVA. VENXXIVA (tiopronin) delayed-release tablets, for oral use Initial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
VENXXIVA is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone. Additional pediatric use information is approved for Mission Pharmacal Company’s Thiola EC (tiopronin delayed-release) tablets. However, due to Mission Pharmacal Company’s marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- tiopronin
- product_names
- tiopronin
- ndc
- 70709-121, 70709-123, 70709-121-30, 70709-123-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en